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Abstract 
When it comes to malignant neoplasms of the liver, their overall division is primary and 
secondary. Primary ones are those tumors that originate from liver tissue itself, and secondary 
are tumors that originate from another organ and have metastases present in the liver. Every year 
there are around 360 people diagnosed with a primary liver tumor, and it is more common in 
men and more common in the age group of over 65. The method used for the purposes of this 
thesis is a retrospective analysis of the data obtained from the State Statistical Office of the 
Republic of Northern Macedonia and outpatient polyclinic morbidities. The paper analyzes the 
total number of patients in Radovis, Stip and Probistip in 2007 and 2018 and deceased patients at 
the level of the Republic of Northern Macedonia in 2007 and 2017. In comparison of the number 
of deaths in 2007 and with those in 2017 it can be concluded that the number of deaths has 
decreased from 207 to 143 or 64 patients. This is thanks to the development and widespread use 
of imaging methods such as UC,CT and MRI used to detect the disease in the earlier phase. 
Mortality has also been reduced due to the modern the rapeuticapproach which provide greater 
survival. 
Keywords – analysis, liver, cancer, neoplasms, oncology 
I. Introduction 
Hepatocellular carcinoma is ranked eighth as the most common cancer in the world and the most 
common primary liver cancer and third in cancer mortality. 
When it comes to malignant neoplasms of the liver, their overall division is primary and 
secondary. Primary ones are those tumors that originate from liver tissue itself, and secondary 
are tumors that originate from another organ and have metastases present in the liver. Every year 
there are around 360 people diagnosed with a primary liver tumor, and it is more common in 
men and more common in the age group of over 65. 
The etiology is not known with certainty but high risk factors are patients with hepatitis B or C 
infection, alcohol consumption, cirrhosis of the liver and others. 
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Further in the clinical picture, usually in the early stages of both primary and secondary 
malignant tumors, patients are usually asymptomatic. They usually appear when the tumor has 
progressed and have: weakness, fatigue, pain in the upper abdomen usually below the right rib 
cage, weight loss, hysteretic syndrome, loss of appetite, abdominal swelling, elevated body 
temperature and etc. 
For diagnosis is used: laboratory tests, imaging methods (UC, RTG, CT, MRI), PET scan and 
biopsy for definitive diagnosis where a sample for patho-histological analysis is taken. 
Staging determines how widespread the tumor is and what is the most appropriate therapeutic 
approach. Stage and therapy also provide a survival prognosis but no physician can predict 
exactly how long a patient will live. 
From the therapy options, there is a surgical intervention (resection) that is most commonly used 
for primary liver cancer. The secondary liver cancer is resected only when it is spread throughout 
the liver or to other parts of the body. Other treatments include: radiofrequency ablation (PSA), 
alcohol injection, cryotherapy, endoscopic palliation, hemoembolization and other. [1-6] 
II. Material and methods 
The method used for the purposes of this thesis is a retrospective analysis of the data obtained 
from the State Statistical Office of the Republic of Northern Macedonia and outpatient polyclinic 
morbidities. 
The materials are extracted from the State Statistical Office of the Republic of Northern 
Macedonia and from the Hygiene-Epidemiological Service in Radovis. 
The paper analyzes the total number of patients in Radovis, Stip and Probistip in 2007 and 2018 
and deceased patients at the level of the Republic of Northern Macedonia in 2007 and 2017. 
III. Results and discussion 
Table.1. Diseased age groups by gender in 2007 
 
 
 
 
 
 
 
Age Men Women 
20-24 0 0 
25-34 0 0 
35-44 0 0 
45-54 1 0 
55-64 0 3 
65-74 1 4 
75+ 3 1 
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According to table 1, it can be concluded that the number of patients in the age group of 65-74 is 
highest. The lowest number of cases is under 44 years. After 44 years it can be concluded that 
the number of people with the highest peak 65-74 is starting to increase and then this is a result 
of mortality after 75 years. This corresponds to the fact that in Macedonia the average life 
expectancy for women is 76.9 and for men it is 74.3 
Table.2. Diseased age groups by gender in 2018 
 
 
 
 
 
 
 
 
 
According to table 2 it can be concluded that the number of patients in the age group of 65-74 
and 75+ is the highest. The lowest number of cases is under 44 years. After 44 years we can 
conclude that the number of people with the highest peak 65-74 and 75+ is starting to grow. The 
comparison between 2007 and 2018 is showing that there is a decrease in the number of patients 
in Radovis, Stip and Probistip. 
Chart 1.Deaths at the level of the Republic of Northern Macedonia in 2007 by gender 
Age Men Women 
20-24 0 0 
25-34 0 0 
35-44 0 0 
45-54 1 0 
55-64 0 0 
65-74 1 1 
75+ 2 0 
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Table.3. Age group of deceased patients by gender in 2007 
 
 
 
 
 
 
 
 
On chart 1 it can be concluded that a higher percentage of deaths nationwide are male, which 
correlates with that the number of diseased and deaths is 3:1 for males. And according to the 
table 3 it can be concluded that according to the age group the most deaths are from 65 to 74 
years. Then the mortality rate decreases which shows the fact that in Macedonia the average life 
expectancy for women is 76.9 and for men is 74.3. 
Chart 2. Deaths at the level of the Republic of Northern Macedonia in 2017 by gender 
 
Age Men Women 
25-34 0 1 
35-44 2 2 
45-54 17 8 
55-64 24 16 
65-74 56 29 
75+ 31 21 
                       International Journal of Medical Science and Health Research 
Vol. 3, No. 05; 2019 
ISSN: 2581-3366 
www.ijmshr.com Page 13 
 
67%
33%
0%
Deaths at the level of the Republic of 
Northern Macedonia in 2017 by gender
Men Women
 
 
Table 4. Age groups of deceased patients by gender  
 
 
 
 
 
 
 
 
 
Compared to 2007 we can say that the number of deaths has decreased due to modern diagnostic 
methods and innovations in the therapeutic approach that prolongs life and the discoverѕ at an 
early stage. 
From the research it can be conclude that the total number of patients in Stip, Radovis and 
Probistip in 2007 is 13 patients. 
Depending on gender, women are more dominant than men. 
Age Men Women  
25-34 0 0 
25-44 3 1 
45-54 9 5 
55-64 25 11 
65-74 31 17 
75+ 28 13 
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From the results it can be concluded that in 2007 according to the age group the most affected 
are men over 75 years and women in the age range 65-74 years. Radovis, Stip, Probistip does not 
cover a large number of respondents ie the statistics are not large in number, which is one of the 
limitations of this research, therefore the results of world statistics cannot be refuted. 
Compared to 2018, the total number of cases in these three regions is 5 patients. According to 
this there is a decrease in the number of patients, probably due to the prevention of hepatitis B 
virus vaccination and the progress in understanding the other etiological factors as well as 
education in the prevention. 
Depending on gender, men dominate over women. Also this year, many cases are not covered so 
that a more precise conclusion can be drawn which sex is more affected even though according 
to world statistics the male to female ratio is 3: 1. This ratio is more pronounced in the survey 
covering deaths at the level of the whole of the Republic of Northern Macedonia where in 2007 
we have a total of 207 persons, of which men are 130 persons and women 77 persons, men 63% 
and females 37%. 
In 2017, there are total of 143 deaths, of which 96 are men and 47 are women, 67% are men and 
33% are women. As there is a larger group of respondents here, the results of worldwide 
statistics suggest that malignant liver tumors are more common in men than in women. 
IV. Conclusion 
In comparison of the number of deaths in 2007 and with those in 2017 it can be concluded that 
the number of deaths has decreased from 207 to 143 or 64 patients. 
This is thanks to the development and widespread use of imaging methods such as UC,CT and 
MRI used to detect the disease in the earlier phase.Mortality has also been reduced due to the 
modern therapeutic approach which provide greater survival. 
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